Vivien O. Obitulata-Ugwu

Potential Role of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist in the Treatment of Bulimia Nervosa

Nkechinyere M. Harry, Kenechukwu Anona, Vivien O. Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, Ibrahim L. Folorunsho, Adeniyi Kayode Busari, Chidalu Ibeneme, Amarachukwu Diala, Victory Afolabi & Gibson O. Anugwom · Journal of Advances in Medicine and Medical Research · 2024

Background: Bulimia nervosa (BN) is a severe eating disorder characterized by recurrent episodes of binge eating followed by compensatory behaviors such as self-induced vomiting, misuse of laxatives, fasting, or excessive exercise. Current treatment strategies, including cognitiv...

Open access Research Article 10.9734/jammr/2024/v36i75514

Intravenous Ketamine in the Treatment of Substance Use Disorder

Chidalu N. Ibeneme, Amarachukwu B. Diala, Victory Afolabi, Nkechinyere M. Harry, Kenechukwu Anona, Vivien O. Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, Ibrahim Folorunsho, Adeniyi Kayode Busari, Chinelo Madekwe & Soji Ojo · Journal of Advances in Medicine and Medical Research · 2024

Background: Substance use disorders (SUD) represent a critical public health issue, significantly contributing to global morbidity and mortality. Traditional pharmacotherapies for SUD have limited efficacy, necessitating innovative treatment approaches. Ketamine, an N-methyl-D-as...

Open access Research Article 10.9734/jammr/2024/v36i105596